Abstract:OBJECTIVE:To investigate the accumulation of advanced glycation end products (AGE) and the inflammatory response of skin and wound in diabetic patients, and to analyze their relationship in vitro.METHODS:Histological staining and immunohistochemical staining was respectively performed on skin and wound tissue specimens collected from 10 patients with Type II diabetes mellitus (diabetes group) and 12 non-diabetic patients with skin injury (control group) to observe the arrangement of collagen and the distribution of inflammatory cells, and to determine the expression levels of AGE and its receptor (RAGE). Malondialdehyde (MDA) levels in skin and wound tissue homogenates were assayed by enzyme-linked immunosorbent assay. In vitro, human neutrophils were isolated and treated with RPMI-1640 culture medium or that containing AGE-human serum albumin in the concentration of 0.315, 0.625, 1.250 mg/mL, and they were identified as normal control (NC) group, low concentration (L) group, moderate concentration (M) group, and high concentration (H) group. Cell viability in each group was determined by MTT colorimetric assay, and the reactive oxygen species (ROS) in cell was measured with 2', 7'-dichlorofluorescein-diacetate. Data were processed with t test.RESULTS:Compared with those of skin in control group, collagens of skin tissues in diabetes group atrophied and disorderly arranged. Inflammatory cells in wounds in diabetes group were dispersed, in which collagens arranged loosely and irregularly, as compared with those of wounds in control group. Expression levels of AGE and RAGE of skin in diabetes group were higher than those in control group. In diabetes and control groups, especially in diabetes group, the numbers of RAGE-positive cells in wound tissue were more than those in skin tissue. Large amount of inflammatory cells with positive expression of RAGE were observed in diabetes group. MDA level of skin and wound tissue in diabetes group was respectively (6.3 ± 1.0), (7.1 ± 2.4) nmol per milligram protein, which were obviously higher than those in control group [(2.9 ± 1.0), (3.6 ± 1.4) nmol per milligram protein, with t value respectively 8.017, 4.349, P < 0.05 or P < 0.01]. Cell viability and ROS levels in neutrophils were increased in L, M, and H groups [(59 ± 8)%, (77 ± 5)%, (67 ± 6)% and 1.67 ± 0.14, 2.13 ± 0.17, 3.48 ± 0.48] as compared with those in NC group [(34 ± 5)% and 0.58 ± 0.06, with t value respectively 7.195, 14.890, 11.130 and 20.195, 24.905, 16.864, P < 0.05 or P < 0.01].CONCLUSIONS:Abnormal oxidative stress in diabetic skin leads to an atypical origin of wound repair. AGE-RAGE effect is a critical mediator for oxidative stress in diabetic wound tissue during wound healing.

Effects of Extracellular Matrix Glycosylation on Proliferation and Apoptosis of Human Dermal Fibroblasts Via the Receptor for Advanced Glycosylated End Products.

Effects of Extracellular Matrix Glycation on the Balance of Proliferation and Apoptosis in Human Dermal Fibroblasts

Advanced Glycation End Products Facilitate Proliferation and Reduce Early Apoptosis of Cardiac Microvascular Endothelial Cell Via PKCβ Signaling Pathway: Insight from Diabetic Cardiomyopathy

Effect of extracellular matrix glycation on dermal fibroblasts

[Effects of Advanced Glycation End Products and Its Receptor on Oxidative Stress in Diabetic Wounds].

Effects of high concentrations of glucose on the biological behavior of dermal fibroblast in diabetic rats

AGEs and chronic subclinical inflammation in diabetes: disorders of immune system.

Effects of Different Courses of Disease on the Biological Behavior of Dermal Fibroblasts in Diabetic Rats

Advanced Glycation End Products (ages) Induce Apoptosis of Fibroblasts by Activation of NLRP3 Inflammasome Via Reactive Oxygen Species (ROS) Signaling Pathway.

Biological Effects Induced by Specific Advanced Glycation End Products in the Reconstructed Skin Model of Aging

Advanced Glycation End Products Induce Tubular Epithelial-Myofibroblast Transition through the RAGE-ERK1/2 MAP Kinase Signaling Pathway

Accumulation of Advanced Glycation Endproducts and Subclinical Inflammation in Deep Tissues of Adult Patients with and Without Diabetes.

Advanced glycation end products activate Smad signaling via TGF- -dependent and -independent mechanisms: implications for diabetic renal and vascular disease

Effects of advanced glycation end products on neutrophil migration and aggregation in diabetic wounds

Correlative study of advanced glycation end products (AGE) and diabetic skin with microangiopathy

Influence of high glucose and AGE environment on the proliferation, apoptosis, paracrine effects, and cytokine expression of human adipose stem cells in vitro

Increased Glycated Basic Fibroblast Growth Factor in Diabetic Skin Reduces the Cell Viability and Angiogenesis of Human Dermal Microvascular Endothelial Cells

Unveiling the mechanism of high sugar diet induced advanced glycosylation end products damage skin structure via extracellular matrix–receptor interaction pathway

[Effect of Advanced Glycosylation End Products on Cell Cycle of Epidermal Keratinocyte and the Role of Signal Pathway].

The link between advanced glycation end products and apoptosis in delayed wound healing

Inhibition of Methylglyoxal-Induced AGEs/RAGE Expression Contributes to Dermal Protection by N-Acetyl-L-Cysteine